EU official: Two vaccines could be authorised soon

PTI Brussels | Updated on November 20, 2020 Published on November 20, 2020

European Commission President Ursula von der Leyen   -  REUTERS

Conditional market authorisation may happen as early as the second half of December

The European Union’s top official said Thursday that two Covid-19 vaccines could receive conditional market authorisation as early as the second half of December.

Speaking after a meeting of EU leaders, European Commission president Ursula von der Leyen said the vaccines developed by Moderna and Pfizer, which created its serum with German drugmaker BioNTech, could be approved by the end of the year by the European Medicines Agency (EMA) if all proceeds now without any problem.

Also read: EU to buy up to 300 million doses of Pfizer-BioNTech vaccine

Von der Leyen added this is the very first step to be able to be on the market. Von der Leyen said the EMA is in constant contact with the FDA to synchronise the assessment of the vaccines.

Also read: ‘We can stop Covid-19’: Moderna vaccine success gives world more hope

The European commission has sealed deals with several pharmaceutical companies including BioNTech and Pfizer to buy millions of doses of vaccines on behalf of all EU Member States. Von der Leyen said earlier this week the commission hopes a deal with Moderna will be soon finalised.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on November 20, 2020
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.